STOCK TITAN
  1. Home
  2. Sec-filings
  3. ARDT
  4. [144] Ardent Health, Inc. SEC Filing

Ardent Health (NYSE: ARDT) ex-exec lines up 2026 sale of stock grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) is the issuer for a planned resale of common stock under Rule 144 by former officer and director Martin Bonick. The shares are held at Fidelity Brokerage Services LLC. The notice lists a proposed sale on the NYSE on 08/18/2026.

The securities to be sold relate to restricted stock vesting awards from the issuer, including 19,990 shares vesting on 03/31/2025 and 15,940 shares vesting on 03/31/2026, both described as compensation. Fidelity signed the notice as attorney-in-fact for Bonick.

Positive

  • None.

Negative

  • None.
Shares held in brokerage account 35,930 shares Ardent Health, Inc. common stock position at Fidelity Brokerage Services LLC
Indicated value of held shares $393,481.70 Approximate value of 35,930 Ardent Health, Inc. shares
Shares from 03/31/2025 restricted stock vesting 19,990 shares Common stock awarded as compensation vesting on 03/31/2025
Shares from 03/31/2026 restricted stock vesting 15,940 shares Common stock awarded as compensation vesting on 03/31/2026
Proposed sale date 08/18/2026 Potential sale of Ardent Health, Inc. common stock on NYSE
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 03/31/2025 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
compensation financial
"15940 | 03/31/2026 | Compensation"

FAQ

What does the Form 144 filing mean for Ardent Health, Inc. (ARDT)?
The filing reports a planned resale of Ardent Health, Inc. common stock under Rule 144 by former officer and director Martin Bonick. It is a regulatory notice of potential sales, not a new issuance of shares by the company.

Who is selling Ardent Health, Inc. (ARDT) shares in this Form 144?
The Form 144 lists Martin Bonick, a former officer and director of Ardent Health, Inc., as the person for whose account the securities may be sold. Fidelity Brokerage Services LLC acts as the broker and attorney-in-fact for this sale notice.

What is the reported current holding for the Ardent Health, Inc. (ARDT) account?
The Form 144 lists 35,930 shares of Ardent Health, Inc. common stock in the Fidelity Brokerage Services LLC account, with an indicated value of $393,481.70. This figure provides context for the size of the potential sales.

When are the Ardent Health, Inc. (ARDT) shares expected to be sold?
The filing indicates a proposed sale date of 08/18/2026 on the NYSE for the common stock held. Form 144 notices outline potential sales and do not guarantee that all listed shares will actually be sold.

What is the source of the Ardent Health, Inc. (ARDT) shares to be sold?
The shares identified for sale come from restricted stock vesting awards granted by Ardent Health, Inc. to Martin Bonick. The filing describes these awards as compensation from the issuer, vesting on specific future dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR